Mayo Clinic has contributed to venture firm Qiming Venture Partners' $935m Qiming VI fund, announced alongside a $334m corporate-backed fund.
China-based venture capital firm Qiming Venture Partners closed a $935m fund on Monday, securing capital from limited partners including medical practice and research group Mayo Clinic.
Qiming Venture USD Fund VI’s LPs also included Princeton University, Massachusetts Institute of Technology and Duke University as well as superannuation fund NGS Super, Commonfund, Hall Capital Partners and Dietrich Foundation.
The vehicle was announced alongside two other funds: the Chinese yuan-denominated Qiming Venture RMB Fund V (Qiming RMB V), which has attracted RMB2.1bn…